Page last updated: 2024-10-28

hydroxychloroquine and Ebola Hemorrhagic Fever

hydroxychloroquine has been researched along with Ebola Hemorrhagic Fever in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Guharoy, R1
Krenzelok, E1
Zhang, P1
Bu, Y1
Jiang, P1
Shi, X1
Lun, B1
Chen, C1
Syafiandini, AF1
Ding, Y1
Song, M1

Other Studies

2 other studies available for hydroxychloroquine and Ebola Hemorrhagic Fever

ArticleYear
Searching for COVID-19 treatments: First, do no harm.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, 10-30, Volume: 77, Issue:22

    Topics: Antiviral Agents; Azithromycin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repo

2020
Toward a Coronavirus Knowledge Graph.
    Genes, 2021, 06-29, Volume: 12, Issue:7

    Topics: Chloroquine; Computer Graphics; COVID-19; Databases, Factual; Hemorrhagic Fever, Ebola; Humans; Hydr

2021